Biallelic gene mutations for the diagnosis of neonatal systemic

The present invention relates to a method and kit for identifying a subject having or at risk of having or developing an isolated neonatal systemic […]

Method for discriminating mono-immunotherapy from combined

Combination therapy with anti-PD-1 and anti-CTLA-4 is now indicated in many cancers. It appears to be more effective than anti-PD-1 monotherapy, but […]

A gene signature for diagnosing stimulator of interferon genes

Gain-of-function mutations in STING1, that codes for the Stimulator of Interferon Gene (STING), result in a severe autoinflammatory disease termed […]

The circular rna circltbp2 as a biomarker and biotarget in

Intrahepatic cholangiocarcinoma (iCCA) is a deadly cancer worldwide with an increasing incidence and limited therapeutic options. Therefore, there is […]

Indole-3-propionic acid as an important contributor to viral infection

The gut-to-lung axis is critical during respiratory infections, including influenza A virus (IAV) infection. In the present study, the inventors used […]

Vasorin as a biomarker and biotarget in nephrology

Aiming to identify factors underlying podocytes loss, the inventors revealed a markedly decreased expression of Vasorin (VASN) using comparative deep […]

Methods for prognosis and monitoring pulmonaryhypertension

In the present invention, in Pulmonary Arterial Hypertension (PAH) patient/u2019s blood samples (EFFORT cohort), inventors results indicate that […]

Non-invasive diagnosis of steatohepatitis based on cytokeratin 18 in

The invention relates to the field of diagnosing steatohepatitis, in particular alcoholic steatohepatitis. By following studies on a cohort of nearly […]

Use of the population of slamf4+ ccr5+ effector memory cd4+ t cells as

CD4+ Foxp3- conventional T cells (Tconv) play a key role in the inflammatory process involved in rheumatoid arthritis (RA). It is now becoming […]

Method for determining the relative age of red blood cells

Glycated Hb was measured and compared between five healthy donors (AA), seven non-diabetic and non-transfused homozygous SCD patients (SS) and five […]